PD-L1 overexpression has been detected in different types of cancers including melanomas [30], pancreatic cancer [31], colorectal cancer [32], lung cancer cells [33], head and neck cancers (HNCs), and OSCC [34]. This evidence concerns the gene CD274 and familial pancreatic carcinoma.